phosphodiesterase 7B (PDE7B) (Middle Region) Peptide
PDE7B
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN981519
Quick Overview for phosphodiesterase 7B (PDE7B) (Middle Region) Peptide (ABIN981519)
Target
PDE7B
(phosphodiesterase 7B (PDE7B))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-PDE7B antibody (Catalog #: ARP55364_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PDE7B (phosphodiesterase 7B (PDE7B))
-
Background
-
The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates a
Alias Symbols: MGC88256, bA472E5.1
Protein Size: 450 -
Molecular Weight
- 52 kDa
-
Gene ID
- 27115
-
NCBI Accession
- NM_018945, NP_061818
-
UniProt
- Q9NP56
Target
-
You are here:
